APA引用形式

Lin, Z., Chen, B., Hung, Y., Huang, P., Shen, Y., Shao, Y., . . . Hsu, C. (2020). A Multicenter Phase II Study of Second‐Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First‐Line Sorafenib Monotherapy. Oncologist.

シカゴスタイル引用形

Lin, Zhong‐Zhe, et al. "A Multicenter Phase II Study of Second‐Line Axitinib for Patients With Advanced Hepatocellular Carcinoma Failing First‐Line Sorafenib Monotherapy." Oncologist 2020.

MLA引用形式

Lin, Zhong‐Zhe, et al. "A Multicenter Phase II Study of Second‐Line Axitinib for Patients With Advanced Hepatocellular Carcinoma Failing First‐Line Sorafenib Monotherapy." Oncologist 2020.